Key result
Triple or dual antithrombotic therapy in patients with atrial fibrillation undergoing stent implantation requires careful balancing of ischemic benefits against bleeding threats.
Authors
Loading...
Key points are not available for this paper at this time.
Huber et al. (2013) studied this question. Triple or dual antithrombotic therapy in patients with atrial fibrillation undergoing stent implantation requires careful balancing of ischemic benefits against bleeding threats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: